Mark De Ridder

7.8k total citations · 1 hit paper
199 papers, 5.2k citations indexed

About

Mark De Ridder is a scholar working on Radiology, Nuclear Medicine and Imaging, Radiation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark De Ridder has authored 199 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Radiology, Nuclear Medicine and Imaging, 77 papers in Radiation and 68 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark De Ridder's work include Advanced Radiotherapy Techniques (76 papers), Medical Imaging Techniques and Applications (41 papers) and Lung Cancer Diagnosis and Treatment (27 papers). Mark De Ridder is often cited by papers focused on Advanced Radiotherapy Techniques (76 papers), Medical Imaging Techniques and Applications (41 papers) and Lung Cancer Diagnosis and Treatment (27 papers). Mark De Ridder collaborates with scholars based in Belgium, United States and Netherlands. Mark De Ridder's co-authors include Guy Storme, Dirk Verellen, Thierry Gevaert, Benedikt Engels, Koen Tournel, Michaël Duchateau, Nadine Linthout, C. Collen, Heng Jiang and Truus Reynders and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mark De Ridder

191 papers receiving 5.1k citations

Hit Papers

Stromal contribution to the colorectal cancer transcriptome 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark De Ridder Belgium 39 2.1k 2.1k 1.7k 1.4k 798 199 5.2k
Andreas Rimner United States 44 4.1k 1.9× 1.4k 0.7× 2.2k 1.3× 1.8k 1.3× 651 0.8× 289 7.2k
N.G. Burnet United Kingdom 42 2.0k 1.0× 1.5k 0.7× 2.8k 1.6× 1.1k 0.7× 1.2k 1.5× 182 6.3k
Jeffrey Y.C. Wong United States 43 1.8k 0.8× 1.3k 0.6× 2.7k 1.5× 1.5k 1.1× 374 0.5× 214 5.4k
Daniel Zips Germany 42 2.5k 1.2× 1.5k 0.7× 2.6k 1.5× 1.8k 1.3× 1.9k 2.3× 310 6.9k
Shankar Siva Australia 46 4.6k 2.1× 1.7k 0.8× 2.7k 1.6× 1.9k 1.4× 893 1.1× 313 7.3k
Maximilian Niyazi Germany 40 2.3k 1.1× 1.4k 0.7× 2.2k 1.3× 928 0.7× 1.2k 1.5× 270 6.2k
Tatsuya Ohno Japan 38 2.8k 1.3× 1.7k 0.8× 1.2k 0.7× 1.4k 1.0× 500 0.6× 400 6.1k
Steven J. Chmura United States 39 2.5k 1.2× 1.0k 0.5× 1.2k 0.7× 2.5k 1.8× 868 1.1× 172 6.0k
Dirk De Ruysscher Netherlands 48 5.0k 2.4× 2.2k 1.0× 3.1k 1.8× 2.8k 2.0× 921 1.2× 237 8.4k
Ute Ganswindt Germany 38 2.2k 1.1× 1.3k 0.6× 1.5k 0.8× 635 0.4× 667 0.8× 166 4.4k

Countries citing papers authored by Mark De Ridder

Since Specialization
Citations

This map shows the geographic impact of Mark De Ridder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark De Ridder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark De Ridder more than expected).

Fields of papers citing papers by Mark De Ridder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark De Ridder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark De Ridder. The network helps show where Mark De Ridder may publish in the future.

Co-authorship network of co-authors of Mark De Ridder

This figure shows the co-authorship network connecting the top 25 collaborators of Mark De Ridder. A scholar is included among the top collaborators of Mark De Ridder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark De Ridder. Mark De Ridder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dufait, Inès, et al.. (2024). Ferroptosis: Frenemy of Radiotherapy. International Journal of Molecular Sciences. 25(7). 3641–3641. 13 indexed citations
2.
Pivodic, Lara, et al.. (2024). Intensive Longitudinal Methods Among Adults With Breast or Lung Cancer: Scoping Review. Journal of Medical Internet Research. 26. e50224–e50224. 4 indexed citations
5.
Parijs, Hilde Van, et al.. (2024). Radiation-induced cutaneous vasculopathy of the breast: a rare case report. World Journal of Surgical Oncology. 22(1). 60–60.
6.
Engels, Benedikt, Antonino De Paoli, E. Delmastro, et al.. (2023). Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: Long-Term Results of a Multicenter Randomized Study. Cancers. 15(15). 3869–3869. 1 indexed citations
7.
Barbé, Kurt, et al.. (2023). Introduction of ultra-hypofractionation in breast cancer: Implications for costs and resource use. Radiotherapy and Oncology. 190. 110010–110010. 4 indexed citations
9.
Vinh‐Hung, Vincent, Nele Adriaenssens, Hilde Van Parijs, et al.. (2022). Lung-Heart Outcomes and Mortality through the 2020 COVID-19 Pandemic in a Prospective Cohort of Breast Cancer Radiotherapy Patients. Cancers. 14(24). 6241–6241. 1 indexed citations
10.
Leemans, Kathleen & Mark De Ridder. (2021). Cognition: development of a cognitive testing battery on the iPad for the evaluation of patients with brain Mets. Acta Neurologica Belgica. 122(1). 145–152. 2 indexed citations
11.
Rogiers, Anne, Christophe Leys, Adrian Schembri, et al.. (2020). Neurocognitive Function, Psychosocial Outcome, and Health‐Related Quality of Life of the First‐Generation Metastatic Melanoma Survivors Treated with Ipilimumab. Journal of Immunology Research. 2020(1). 2192480–2192480. 31 indexed citations
12.
Rogiers, Anne, Jennifer Cremer, Gil Awada, et al.. (2019). Emotional disturbances, social outcome and neurocognitive function in advanced melanoma survivors treated with pembrolizumab. Journal of Translational Medicine. 17. 7. 1 indexed citations
13.
Engels, Benedikt, Antonino De Paoli, Fernando Muñoz, et al.. (2014). Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiation therapy for T3-4 Rectal Cancer: Interim Analysis of a Multicentric Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 90(1). S22–S23. 1 indexed citations
14.
Gevaert, Thierry, Marc Levivier, T. Lacornerie, et al.. (2013). Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas. VUBIR (Vrije Universiteit Brussel). 2 indexed citations
15.
Engels, Benedikt, et al.. (2013). Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival. Annals of Oncology. 25(2). 467–471. 83 indexed citations
16.
Versmessen, Harijati, Vincent Vinh‐Hung, Hilde Van Parijs, et al.. (2012). Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy. BMC Cancer. 12(1). 495–495. 40 indexed citations
17.
Goetghebeur, Els, Ronan Van Rossem, Tom Boterberg, et al.. (2011). Quality Assurance of rectal cancer diagnosis and treatment – phase 3. 1 indexed citations
18.
Ridder, Mark De, et al.. (2008). Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.. PubMed. 95(3). 282–91. 25 indexed citations
19.
Ridder, Mark De, et al.. (2000). Imaging in radiotherapy. European Journal of Radiology. 36(1). 41–48. 13 indexed citations
20.
Mechelen, Willem van, Hynek Hlobil, Wiebren Zijlstra, Mark De Ridder, & H.C.G. Kemper. (1992). Is Range of Motion of the Hip and Ankle Joint Related to Running Injuries?. International Journal of Sports Medicine. 13(8). 605–610. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026